These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14458647)

  • 1. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

  • 2. Triacetyloleandomycin: a report on its use in a general hospital.
    LEFEBVRE M; BELIVEAU D; DESILETS R; SIMARD J; CHARBONNEAU PE; LAFORTUNE L; ROY J
    Antibiot Annu; 1959-1960; 7():755-60. PubMed ID: 14415263
    [No Abstract]   [Full Text] [Related]  

  • 3. Triacetyloleandomycin with triple sulfa. Its role in the control of staphylococcus and streptococcus infections in the urinary tract.
    CARROLL G; GIBAS D; KARELLOS D
    JAMA; 1960 Nov; 174():1603-5. PubMed ID: 13691064
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the antibiotic triacetyloleandomycin and the combination preparation tetracycline-oleandomycin in childhood].
    DIETEL V; MEISSNER F
    Dtsch Gesundheitsw; 1961 Dec; 16():2470-4. PubMed ID: 13886293
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenge of triacetyloleandomycin in pediatric infections.
    NEWSOME CK
    J Indiana State Med Assoc; 1960 Jun; 53():1131-3. PubMed ID: 14426838
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of triacetyloleandomycin in general infections of institutionalized patients.
    CARTER CH
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():125-8. PubMed ID: 13808017
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of otitis media with an oral antibiotic (triacetyloleandomycin).
    FOWLER PD
    Practitioner; 1961 Nov; 187():684-8. PubMed ID: 13894346
    [No Abstract]   [Full Text] [Related]  

  • 8. Triacetyloleandomycin in the treatment of severe infections in infants and children.
    OZYAZICI A; COHEN HJ; PRIGOT A
    Q Rev Pediatr; 1960; 15():102-9. PubMed ID: 14429613
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of dysentery caused by antibiotic-resistant strains with triacetyloleandomycin (Taocin)].
    TOTANI T; YAMANAKA T; IIDA M; INAMURA Y
    Nihon Densenbyo Gakkai Zasshi; 1962 Jul; 36():139-51. PubMed ID: 13922102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic trial of triacetyloleandomycin (TAO) in infections caused by gram-positive bacteria and Klebsiella].
    KRALJEVIC R; BORGONO JM; VILLALOBOS M; MENDOZA A
    Rev Med Chil; 1960 Aug; 88():644-7. PubMed ID: 13753910
    [No Abstract]   [Full Text] [Related]  

  • 11. Triacetyloleandomycin (TAO)-its value in acne and certain pyogenic skin eruptions. J.
    LOVEMAN AB; HAMMOND K
    J Ky Med Assoc; 1959 Dec; 57():1507-10. PubMed ID: 13853712
    [No Abstract]   [Full Text] [Related]  

  • 12. Acne vulgaris treated with triacetyloleandomycin.
    PARKER W
    Med Times; 1962 Mar; 90():310-2. PubMed ID: 14483935
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin.
    RIPBERGER FM; ANDERSON RH; PALMER RE
    Antibiotic Med Clin Ther (New York); 1959 Nov; 6():662-9. PubMed ID: 14437535
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triacetyloleandomycin (P.A. 777)].
    WAREMBOURG H; DESMET G; LEKIEFFRE J
    Lille Med; 1961 Mar; 6():238-43. PubMed ID: 13783140
    [No Abstract]   [Full Text] [Related]  

  • 15. Some in vitro susceptibility results with triacetyloleandomycin.
    HORTON GE; DAVIS JW
    Antibiot Chemother (Northfield); 1962 Jun; 12():404-10. PubMed ID: 14449073
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of triacetyloleandomycin: in vitro and in vivo studies.
    WERTHAMER S; PECORA CL
    Antibiotic Med Clin Ther (New York); 1960 Sep; 7():560-5. PubMed ID: 13844064
    [No Abstract]   [Full Text] [Related]  

  • 17. Triacetyloleandomycin: further observations on the treatment of acne and pyodermas.
    OLANSKY S; MCCORMICK GE
    Antibiot Annu; 1959-1960; 7():652-6. PubMed ID: 14428587
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin.
    QUINN EL; COLVILLE JM; COX F
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():103-8. PubMed ID: 14435562
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of granuloma inguinale with triacetyloleandomycin. Report of a case.
    KERDEL-VEGAS F; CONVIT J; SOTO JM
    Arch Dermatol; 1961 Aug; 84():248-55. PubMed ID: 13752597
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of triacetyloleandomycin in the treatment of pustular and cystic acne: a double blind study.
    MORGINSON WJ; ESKELSON YD
    Antibiot Annu; 1959-1960; 7():657-9. PubMed ID: 14424141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.